Loading patent…
AssigneeCanTrust LifeScience Corp.
InventorsGrace Qiao, Lili Zhang, Feng Qiao, Longjun Dai
Estimating the term…
Disclosed here is a novel use of a pharmaceutical composition comprising glutathione or its pharmaceutically acceptable salts or derivatives as active ingredient, in the forms of tablets, capsules, powder, spray and/or liquid, through oral administration, intervene injection, inhale and/or skin transmission, to treat and prevent gout and lead nephropathy. Embodiments of gout and lead nephropathy treatable by the pharmaceutical composition described herein include, without limitation, gout, kidney stones, tophi, hyperuricemia, blood lead, renal disease (lead nephropathy), complications thereof, as well as other conditions caused by lifestyle, genetics, medical conditions, and blood lead level. Symptoms treatable may include inflammatory arthritis, which typically involves a red, tender, hot, and swollen joint.
A method for treating gout and/or lead nephropathy, comprising administrating to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of glutathione or a pharmaceutically acceptable salt thereof.
A method for treating a disease or condition selected from the group consisting of chronic gouty arthritis, acute inflammatory arthritis, uric acid nephropathy, kidney stones, tophi, and hyperuricemia, comprising administrating to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of glutathione or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition for treatment of gout and/or lead nephropathy, comprising a therapeutically effective amount of glutathione or a pharmaceutically acceptable salt thereof, wherein glutathione is the sole active ingredient of the pharmaceutical composition, and wherein the pharmaceutical composition is adapted for oral administration.
Dependencies are inferred from the claim text.